Wells Fargo Starts Calithera Biosciences (CALA) at Outperform
Tweet
Share
E-mailGet Alerts CALA Hot Sheet
Price: $0.00 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 15
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 22 | New: 15
Join SI Premium – FREE
Wells Fargo initiated coverage on Calithera Biosciences (NASDAQ: CALA) with an Outperform rating and a price target of $19-$20.
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $11.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Red Rock Resorts (RRR) to Overweight
- Benchmark Starts First BanCorp (FBP) at Buy
- Wells Fargo Starts Atmos Energy (ATO) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
